Ignite Creation Date:
2024-07-17 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06499025
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-07-07
Brief Title:
Treatment of Relapsed or Refractory t8 21 AML With Targeted AML1-ETO Neoantigen Cytotoxic T Cells CTL
Sponsor:
BGI China
Organization:
BGI China
Organization Data
Organization:
BGI China
Class:
OTHER
Study ID:
BGI-007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BGI China
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Shenzhen University General Hospital | OTHER |